Correlation Between Volitionrx and Exagen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Volitionrx and Exagen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Volitionrx and Exagen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Volitionrx and Exagen Inc, you can compare the effects of market volatilities on Volitionrx and Exagen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Volitionrx with a short position of Exagen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Volitionrx and Exagen.

Diversification Opportunities for Volitionrx and Exagen

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between Volitionrx and Exagen is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Volitionrx and Exagen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exagen Inc and Volitionrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Volitionrx are associated (or correlated) with Exagen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exagen Inc has no effect on the direction of Volitionrx i.e., Volitionrx and Exagen go up and down completely randomly.

Pair Corralation between Volitionrx and Exagen

Given the investment horizon of 90 days Volitionrx is expected to generate 2.7 times less return on investment than Exagen. But when comparing it to its historical volatility, Volitionrx is 1.05 times less risky than Exagen. It trades about 0.13 of its potential returns per unit of risk. Exagen Inc is currently generating about 0.35 of returns per unit of risk over similar time horizon. If you would invest  257.00  in Exagen Inc on September 2, 2024 and sell it today you would earn a total of  140.00  from holding Exagen Inc or generate 54.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Volitionrx  vs.  Exagen Inc

 Performance 
       Timeline  
Volitionrx 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Volitionrx are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Volitionrx may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Exagen Inc 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Exagen Inc are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Exagen displayed solid returns over the last few months and may actually be approaching a breakup point.

Volitionrx and Exagen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Volitionrx and Exagen

The main advantage of trading using opposite Volitionrx and Exagen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Volitionrx position performs unexpectedly, Exagen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exagen will offset losses from the drop in Exagen's long position.
The idea behind Volitionrx and Exagen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum